Growth factor-mediated stabilization of amyloid precursor protein mRNA is mediated by a conserved 29-nucleotide sequence in the 3'-untranslated region

Journal of Neurochemistry

Volumn 74, Issue 1, 2000, Pages 52-59

  Rajagopalan, Lakshman E ^a   Malter, James S ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

3' untranslated region; Amy loid protein precursor; Capillary endothelial cells; Growth factor; MRNA decay

Indexed keywords

AMYLOID PRECURSOR PROTEIN; BASIC FIBROBLAST GROWTH FACTOR; EPIDERMAL GROWTH FACTOR; GROWTH FACTOR; SOMATOMEDIN; VASCULOTROPIN;

ARTICLE; CAPILLARY ENDOTHELIUM; CELL PROLIFERATION; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REGULATORY MECHANISM; STOP CODON; UNTRANSLATED REGION;

3' UNTRANSLATED REGIONS; AMYLOID BETA-PROTEIN PRECURSOR; BASE SEQUENCE; BLOOD PHYSIOLOGY; CELLS, CULTURED; CONSERVED SEQUENCE; CULTURE MEDIA; GROWTH SUBSTANCES; HALF-LIFE; HOMEOSTASIS; HUMANS; RNA STABILITY; RNA, MESSENGER; TRANSFECTION;

EID: 0033981159     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2000.0740052.x     Document Type: Article

References (47)

1. Adroer R., Lopez-Acedo C., and Oliva R. (1997) Conserved elements in the 5′ regulatory region of the amyloid precursor protein gene in primates. Neurosci. Lett. 226, 203-206.
2. Altus M. S. and Nagamine Y. (1991) Protein synthesis inhibition stabilizes urokinase-type plasminogen activator mRNA. Studies in vivo and in cell-free decay reactions. J. Biol. Chem. 266, 21190-21196.
3. Brewer G. and Ross J. (1989) Regulation of c-myc mRNA stability in vitro by a labile destabilizer with an essential nucleic acid component. Mol. Cell. Biol. 9, 1996-2006.
4. Castano E. M., Prelli F., Soto C., Beavis R., Matsubara E., Shoji M., and Frangione B. (1996) The length of amyloid-beta in hereditary cerebral hemorrhage with amyloidosis, Dutch type. Implications for the role of amyloid-beta 1-42 in Alzheimer's disease. J. Biol. Chem. 271, 32185-32191.
5. 2-terminal kinase pathway. Science 280, 1945-1949.
6. Chung S., Eckrich M., Perrone-Bizzozero N., Kohn D. T., and Furneaux H. (1997) The elav-like proteins bind to a conserved regulatory element in the 3′-untranslated region of GAP-43 mRNA. J. Biol. Chem. 272, 6593-6598.
7. Citron M., Oltersdorf T., Haass C., McConlogue L., Hung A. Y., Seubert P., Vigo-Pelfrey C., Lieberburg I., and Selkoe D. J. (1992) Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production. Nature 360, 672-674.
8. Connor B., Beilharz E. J., Williams C., Synek B., Gluckman P. D., Faull R. L., and Dragunow M. (1997) Insulin-like growth factor-1 (IGF-1) immunoreactivity in the Alzheimer's disease temporal cortex and hippocampus. Brain Res. Mol. Brain Res. 49, 283-290.
9. de la Monte S. M., Ng S. C., and Hsu D. W. (1995) Aberrant GAP-43 gene expression in Alzheimer's disease. Am. J. Pathol. 147, 934-946.
10. Fukuchi K., Kamino K., Deeb S. S., Smith A. C., Dang T., and Martin G. M. (1992) Overexpression of amyloid precursor protein alters its normal processing and is associated with neurotoxicity. Biochem. Biophys. Res. Commun. 182, 165-173.
11. Gacheru S. N., Thomas K. M., Murray S. A., Csiszar K., Smith-Mungo L. I., and Kagan H. M. (1997) Transcriptional and posttranscriptional control of lysyl oxidase expression in vascular smooth muscle cells: effects of TGF-beta 1 and serum deprivation. J. Cell. Biochem. 65, 395-407.
12. Goldberg M. A., Gaut C. C., and Bunn H. F. (1991) Erythropoietin mRNA levels are governed by both the rate of gene transcription and posttranscriptional events. Blood 77, 271-277.
13. Goldgaber D., Harris H. W., Hla T., Maciag T., Donnelly R. J., Jacobsen J. S., Vitek M. P., and Gajdusek D. C. (1989) Interleukin 1 regulates synthesis of amyloid β-protein precursor mRNA in human endothelial cells. Proc. Natl. Acad. Sci. USA 86, 7606-7610.
14. Greenberg S. M., Koo E. H., Selkoe D. J., Qiu W. Q., and Kosik K. S. (1994) Secreted beta-amyloid precursor protein stimulates mitogen-activated protein kinase and enhances tau phosphorylation. Proc. Natl. Acad. Sci. USA 91, 7104-7108.
15. Griffin W. S., Stanley L. C., Ling C., White L., MacLeod V., Perrot L. J., White C. L., and Araoz C. (1989) Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc. Natl. Acad Sci. USA 86, 7611-7615.
16. Haass C., Koo E. H., Mellon A., Hung A. Y., and Selkoe D. J. (1992) Targeting of cell-surface β-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments. Nature 357, 500-503.
17. Holtzman D. M., Bayney R. M., Li Y. W., Khosrovi H., Berger C. N., Epstein C. J., and Mobley W. C. (1992) Dysregulation of gene expression in mouse trisomy 16, an animal model of Down's syndrome. EMBO J. 11, 619-627.
18. Johnson S. A., McNeill T., Cordell B., and Finch C. E. (1990) Relation of neuronal APP-751/APP-695 ratio and neuritic plaque density in Alzheimer's disease. Science 248, 854-857.
19. Johnston J. A., Norgren S., Ravid R., Wasco W., Winblad B., Lannfelt L., and Cowburn R. F. (1996) Quantification of APP and APLP2 mRNA in APOE genotyped Alzheimer's disease brains. Brain Res. Mol. Brain Res. 43, 85-95.
20. Kalaria R. N., Cohen D. L., Premkumar D. R., Nag S., LaManna J. C., and Lust W. D. (1998) Vascular endothelial growth factor in Alzheimer's disease and experimental cerebral ischemia. Brain Res. Mol. Brain Res. 62, 101-105.
21. Kindy M. S., Chang C. J., and Sonenshein G. E. (1988) Serum deprivation of vascular smooth muscle cells enhances collagen gene expression. J. Biol. Chem. 263, 11426-11430.
22. Mattson M. P., Barger S. W., Furukawa K., Bruce A. J., Wyss-Coray T., Mark R. J., and Mucke L. (1997) Cellular signalling roles of TGF beta, TNF alpha and beta APP in brain injury responses and Alzheimer's disease. Brain Res. Brain Res. Rev. 23, 47-61.
23. Mayeux R., Ottman R., Tang M. X., Noboa-Bauza L., Marder K., Gurland B., and Stern Y. (1993) Genetic susceptibility and head injury as risk factors for Alzheimer's disease among community-dwelling elderly persons and their first-degree relatives. Ann. Neurol. 33, 494-501.
24. McDonald D. R., Bamberger M. E., Combs C. K., and Landreth G. E. (1998) Beta-amyloid fibrils activate mitogen-activated protein kinase pathways in microglia and THP1 monocytes. J. Neurosci. 18, 4451-4460.
25. McGeer P. L., Schulzer M., and McGeer E. G. (1996) Arthritis and antiinflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies. Neurology 47, 425-432.
26. Mills J. and Reiner P. B. (1999) Regulation of amyloid precursor protein cleavage. J. Neurochem. 72, 443-460.
27. Ming X. F., Kaiser M., and Moroni C. (1998) c-jun N-terminal kinase is involved in AUUUA-mediated interleukin-3 mRNA turnover in mast cells. EMBO J. 17, 6039-6048.
28. Nicoll J. A. R., Roberts G. W., and Graham D. I. (1995) Apolipoprotein E4 allele is associated with deposition of amyloid β-protein following head injury. Nat. Med. 1, 135-137.
29. Premkumar D. R. and Kalaria R. N. (1996) Altered expression of amyloid beta precursor mRNAs in cerebral vessels, meninges, and choroid plexus in Alzheimer's disease. Ann. NY Acad. Sci. 777, 288-292.
30. Rajagopalan L. E. and Malter J. S. (1994) Modulation of granulocyte-macrophage colony-stimulating factor mRNA stability in vitro by the adenosine-uridine binding factor. J. Biol. Chem. 269, 23882-23888.
31. Rajagopalan L. E. and Malter J. S. (1996) Turnover and translation of in vitro synthesized messenger RNAs in transfected, normal cells. J. Biol. Chem. 271, 19871-19876.
32. Rajagopalan L. E., Westmark C. J., Jarzembowski J. A., and Malter J. S. (1998) hnRNP C increases amyloid precursor protein (APP) production by stabilizing APP mRNA. Nucleic Acids Res. 26, 3418-3423.
33. Ringheim G. E., Aschmies S., and Petko W. (1997) Additive effects of basic fibroblast growth factor and phorbol ester on beta-amyloid precursor protein expression and secretion. Neurochem. Int. 30, 475-481.
34. Rogers J. T., Leiter L. M., McPhee J., Cahill C. M., Zhan S.-S., Potter H., and Nilsson L. N. G. (1999) Translation of the Alzheimer amyloid precursor protein mRNA is up-regulated by interleukin-1 through 5′-untranslated region sequences. J. Biol. Chem. 274, 6421-6431.
35. Ross H. J., Sato N., Ueyama Y., and Koeffler H. P. (1991) Cytokine messenger RNA stability is enhanced in tumor cells. Blood 77, 1787-1795.
36. Scheper W., Holthuizen P. E., and Sussenbach J. S. (1996) Growth-condition-dependent regulation of insulin-like growth factor II mRNA stability. Biochem. J. 318, 195-201.
37. Selkoe D. J. (1993) Physiological production of the beta-amyloid protein and the mechanism of Alzheimer's disease. Trends Neurosci. 16, 403-409.
38. Shyu A. B., Greenberg M. E., and Belasco J. G. (1989) The c-fos transcript is targeted for rapid decay by two distinct mRNA degradation pathways. Genes Der. 3, 60-72.
39. Stopa E. G., Gonzalez A. M., Chorsky R., Corona R. J., Alvarez, J., Bird E. D., and Baird A. (1990) Basic fibroblast growth factor in Alzheimer's disease. Biochem. Biophys. Res. Commun. 171, 690-696.
40. Suo Z., Tan J., Placzek A., Crawford F., Fang C., and Mullan M. (1998) Alzheimer's beta amyloid peptides induce inflammatory cascade in human vascular cells: the roles of cytokines and CD40. Brain Res. 807, 110-117.
41. Urakami K., Kataoka J., Okada A., Isoe K., Wakutani Y., Ji Y., Adachi Y., Ohno K., and Takahashi K. (1996) Analysis of amyloid precursor protein mRNAs in skin fibroblasts in Down's syndrome. Dementia 7, 82-85.
42. van der Wal E. A., Gomez-Pinilla F., and Cotman C. W. (1993) Transforming growth factor-beta 1 is in plaques in Alzheimer and Down pathologies. Neuroreport 4, 69-72.
43. Wisdom R. and Lee W. (1991) The protein-coding region of c-myc mRNA contains a sequence that specifies rapid mRNA turnover and induction by protein synthesis inhibitors. Genes Dev. 5, 232-243.
44. Wyss-Coray T., Masliah E, Mallory M., McConlogue L., Johnson-Wood K., Lin C., and Mucke L. (1997) Amyloidogenic role of cytokine TGF-β1 in transgenic mice and in Alzheimer's disease. Nature 389, 603-606.
45. Yang Y., Quitschke W. W., and Brewer G. J. (1998) Upregulation of amyloid precursor protein gene promoter in rat primary hippocampal neurons by phorbol ester. IL-1 and retinoic acid, but not by reactive oxygen species. Brain Res. Mol. Brain Res. 60, 40-49.
46. Yoshikawa K., Aizawa T., and Hayashi Y. (1992) Degeneration in vitro of post-mitotic neurons overexpressing the Alzheimer amyloid protein precursor. Nature 359, 64-67.
47. Zaidi S. H. E. and Malter J. S. (1994) Amyloid precursor protein mRNA stability is controlled by a 29-base element in the 3′-untranslated region. J. Biol. Chem. 269, 24007-24013.